Jul. 01, 2022
Starkey Announced as Winner of Better Business Bureau Torch Award for Ethics
No excerpt
HHTM's mission is to bridge the knowledge gaps in treating hearing loss by providing timely information and lively insights to anyone who cares about hearing loss. Our contributors and readers are drawn from many sectors of the hearing field, including practitioners, researchers, manufacturers, educators, and, importantly, consumers with hearing loss and those who love them.
Jun. 30, 2022
LGBTQ+ Audiologist Round Table
This special episode highlights audiologists who are members of the LGBTQ+ community and their contributions to the profession. They discuss how their identities and careers intertwine and how to best foster an inclusive and compassionate clinical experience for LGBTQ+ providers and patients alike. Panelists include: Kathleen Wallace, Au.D. (She/her/hers) is an audiologist based in New York City. She works
Jun. 29, 2022
AAA Announces 2022 Research Grants in Hearing and Balance Winners
RESTON, VIRGINIA — The American Academy of Audiology Foundation (AAAF) funds annually the American Academy of Audiology’s research program to support students in basic research in hearing and balance. The Academy and the AAAF jointly support this program to award $5,000 each for the Student Investigator Research Grant and the Student Investigator Research Grant—Vestibular. The latter grant is partially funded
Jun. 28, 2022
Meteorologist Meaghan Thomas on Going Public with Hearing Loss and Providing Support to Those in Need
This week, host Shari Eberts is joined by broadcast meteorologist Meaghan Thomas. From the WKRN TV studios in Nashville, Meaghan Thomas speaks to nearly three million people everyday. But when the broadcast meteorologist posted recently on social media about overcoming hearing loss through her new hearing aids, her viewers spoke back. Within days, she received dozens of messages from those
Jun. 27, 2022
CMV Vaccine Breakthrough Offers Hope at Preventing One of Most Common Causes of Congenital Hearing Loss in Children
BRISBANE, AUSTRALIA — Queensland’s QIMR Berghofer Medical Research Institute has developed a breakthrough vaccine candidate against the widespread but little-known cytomegalovirus, or CMV, which can cause hearing loss and other severe disabilities among unborn babies. Congenital CMV is said to be the most common non-genetic cause of congenital hearing loss, causing an estimated 20-25% of all congenital hearing loss cases.
Jun. 27, 2022
HearingUp Announced as New Home of Dr. Cliff Content and New HearingUp Provider Network
No excerpt
Jun. 25, 2022
EHIMA Report Shows Rebound in Global Hearing Aid Sales
No excerpt
Jun. 24, 2022
InnoCaption Co-CEO Joe Duarte Honored with HLAA Lifetime Achievement Award
BUENA PARK, CALIFORNIA – InnoCaption, a mobile app-based provider of real-time captioning of phone calls for the deaf and hard of hearing, announced today that Co-CEO Joe Duarte has been granted the Lifetime Achievement Award at the Hearing Loss Association of America’s (HLAA) 2022 Convention in Tampa, Fla. Throughout his career, Joe has been dedicated to developing technologies and bringing
Jun. 23, 2022
The Role of Audiology in Concussion: Interview with Dr. Liz Fuemmeler
This week, host Ashley Hughes is joined by Liz Fuemmeler, to discuss the role audiologists play in evaluation and management of patients with concussions and head injury. Dr. Fuemmeler discusses how she came to specialize in vestibular audiology, specifically related to concussion as part of an interdisciplinary team of specialists. Be sure to subscribe to the TWIH YouTube channel for the latest
Jun. 22, 2022
FDA Approves Clinical Trial of First Fully Implanted Cochlear Implant
WHITE BEAR LAKE, MINNESOTA – June 21, 2022 – Envoy Medical® Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, today announced the U.S. Food and Drug Administration (FDA) approved its Investigational Device Exemption (IDE) application to begin a clinical trial with its fully implanted Acclaim® cochlear implant. Envoy Medical’s single-center Early Feasibility Study for the Acclaim will take place at